Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
Titel:
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
Auteur:
Lanzetta, Paolo Korobelnik, Jean-François Heier, Jeffrey S Leal, Sergio Holz, Frank G Clark, W Lloyd Eichenbaum, David Iida, Tomohiro Xiaodong, Sun Berliner, Alyson J Schulze, Andrea Schmelter, Thomas Schmidt-Ott, Ursula Zhang, Xin Vitti, Robert Chu, Karen W Reed, Kimberly Rao, Rohini Bhore, Rafia Cheng, Yenchieh Sun, Wei Hirshberg, Boaz Yancopoulos, George D Wong, Tien Y